CONTINGENT FORWARD CONTRACTS - Narrative (Details) - USD ($)	1 Months Ended			2 Months Ended	12 Months Ended
	Apr. 30, 2021	Mar. 31, 2021	Feb. 28, 2021	Apr. 30, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021		Apr. 01, 2021
Forward Contract Indexed to Issuer's Equity [Line Items]
Change in fair value of forward contracts					$ 0	$ 0	$ 454,546,000
Stock price (in dollars per share)									$ 23.78
Eligible Holders
Forward Contract Indexed to Issuer's Equity [Line Items]
Aggregate value of convertible preferred shares approved for issuance			$ 71,000,000
Series E
Forward Contract Indexed to Issuer's Equity [Line Items]
Issuance of Series E convertible preferred stock (in shares)	66,909,408		133,818,821				200,728,229	[1]
Preferred stock, price (in dollars per share)	$ 2.99		$ 2.99	$ 2.99
Issuance of Series E convertible preferred stock			$ 400,000,000				$ 3,206,159,000
Proceeds from issuance of convertible preferred stock	$ 92,900,000	$ 107,100,000	$ 400,000,000	$ 200,000,000	$ 0	$ 0	600,000,000
Series E | Eligible Holders
Forward Contract Indexed to Issuer's Equity [Line Items]
Preferred stock, price (in dollars per share)			$ 2.99
Convertible preferred shares approved for issuance (in shares)			23,737,221
Series E | Additional Purchasers
Forward Contract Indexed to Issuer's Equity [Line Items]
Preferred stock, price (in dollars per share)			$ 2.99
Series E | Management
Forward Contract Indexed to Issuer's Equity [Line Items]
Issuance of Series E convertible preferred stock (in shares)				3,034,194
Series E | Director
Forward Contract Indexed to Issuer's Equity [Line Items]
Issuance of Series E convertible preferred stock (in shares)				1,658,705
Series E | Chief Executive Officer
Forward Contract Indexed to Issuer's Equity [Line Items]
Issuance of Series E convertible preferred stock (in shares)	535,275
Series E Contingent Forward Contract Liability
Forward Contract Indexed to Issuer's Equity [Line Items]
Contingent forward contract, fair value	$ 722,400,000		$ 1,444,900,000	$ 722,400,000			$ 0
Contingent forward contract reclassified to preferred shares	$ 1,200,000,000

[1] The number of shares of convertible preferred stock and common stock issued and outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio (as defined in Note 4 “Reverse Recapitalization”) to give effect to the reverse recapitalization treatment of the Merger. See Note 1 “Description of Business” and Note 4 “Reverse Capitalization” for more information.